Product Information
METRONIDAZOLE 250 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1007 per EA under NDC 62135079590. Its NADAC has been published 116 times since Apr 10, 2024.
The High Outlier badge above means this manufacturer's average price in the Metronidazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
Chartwell RX LLCNDC
62135079590
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA205245On Market Since
11/29/2017
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 250 MG TABLET has been published 116 times since Apr 10, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1007 per EA |
|---|---|
| All-time high | $0.1239 (Oct 16, 2024) |
| All-time low | $0.0623 (Dec 17, 2025) |
| 52-week high | $0.1096 |
| 52-week low | $0.0623 |
| Median price | $0.0924 |
| Average price | $0.0906 |
| Largest weekly change | +35.7% (Sep 18, 2024) |
| Weeks tracked | 116 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 250 MG TABLET, manufactured by Chartwell RX LLC, is $0.1007 per EA (NDC 62135079590), effective Jun 24, 2026.
How has the price of METRONIDAZOLE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 250 MG TABLET has held within roughly two percent of its current level. It has been tracked across 116 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 250 MG TABLET?
Since Apr 10, 2024, the NADAC for METRONIDAZOLE 250 MG TABLET has ranged from a low of $0.0623 (Dec 17, 2025) to a high of $0.1239 (Oct 16, 2024), with a median of $0.0924 per EA.
Are there cheaper alternatives to METRONIDAZOLE 250 MG TABLET?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METRONIDAZOLE 250 MG TABLET, is $0.0970 per EA — about 4% below METRONIDAZOLE 250 MG TABLET.
Who manufactures METRONIDAZOLE 250 MG TABLET?
METRONIDAZOLE 250 MG TABLET (NDC 62135079590) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification